18 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32830548 | Salicylate administration suppresses the inflammatory response to nutrients and improves ovarian function in polycystic ovary syndrome. | 2020 Oct 1 | 1 |
2 | 31440379 | Salsalate Prevents β-Cell Dedifferentiation in OLETF Rats with Type 2 Diabetes through Notch1 Pathway. | 2019 Aug | 3 |
3 | 25644856 | Salsalate treatment improves glycemia without altering adipose tissue in nondiabetic obese hispanics. | 2015 Mar | 1 |
4 | 25683256 | Salsalate has no effect on insulin secretion but decreases insulin clearance: a randomized, placebo-controlled trial in subjects without diabetes. | 2015 Jun | 5 |
5 | 26350812 | Salsalate-induced changes in lipid, lipoprotein, and apoprotein concentrations in overweight or obese, insulin-resistant, nondiabetic individuals. | 2015 Sep-Oct | 3 |
6 | 24963111 | Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled study. | 2014 Jul | 5 |
7 | 25126374 | Salsalate, an old, inexpensive drug with potential new indications: a review of the evidence from 3 recent studies. | 2014 Jun | 2 |
8 | 25317247 | Targeting inflammation in diabetes: Newer therapeutic options. | 2014 Oct 15 | 1 |
9 | 21938543 | Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes. | 2013 Aug | 1 |
10 | 23370525 | A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. | 2013 Apr | 2 |
11 | 23801715 | AMPK: a target for drugs and natural products with effects on both diabetes and cancer. | 2013 Jul | 1 |
12 | 23825542 | Salsalate and Adiponectin Improve Palmitate-Induced Insulin Resistance via Inhibition of Selenoprotein P through the AMPK-FOXO1α Pathway. | 2013 | 1 |
13 | 22784842 | Reduction of insulin resistance and plasma glucose level by salsalate treatment in persons with prediabetes. | 2012 Nov-Dec | 2 |
14 | 21289240 | Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal under insulin-stimulated conditions. | 2011 May | 4 |
15 | 21617098 | Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans. | 2011 Jul | 2 |
16 | 19104769 | The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. | 2009 Mar | 3 |
17 | 17959861 | Salsalate improves glycemia and inflammatory parameters in obese young adults. | 2008 Feb | 2 |
18 | 19337387 | Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. | 2008 May | 1 |